RecruitingPhase 2NCT05201144
A Trial of Phosphodiesterase-5 Inhibitor in Neonatal Congenital Diaphragmatic Hernia (TOP-CDH)
Studying Congenital diaphragmatic hernia
Last synced from ClinicalTrials.gov
ℹ
Clinical trial records are synced from ClinicalTrials.gov through automated extraction.
Report missing dataKey facts
- Sponsor
- University of Utah
- Intervention
- Sildenafil Oral Suspension(drug)
- Enrollment
- 40 enrolled
- Eligibility
- All sexes
- Timeline
- 2022 – 2026
Study locations (1)
- Primary Children's Hospital, Salt Lake City, Utah, United States
Primary source
Recruitment status, site addresses, contacts, and full eligibility criteria can change between syncs. Always verify with the trial team before planning travel or treatment.
Open NCT05201144 on ClinicalTrials.govOther trials for Congenital diaphragmatic hernia
Additional recruiting or active studies for the same condition.
- RECRUITINGNANCT05962346Fetal Endoscopic Tracheal Occlusion for Congenital Diaphragmatic HerniaMauro H. Schenone
- RECRUITINGNANCT05354505Fetal Endoscopic Tracheal Occlusion (FETO) Trial for Congenital Diaphragmatic Hernia (CDH)Vincent Duron
- RECRUITINGPHASE4NCT05213676De-implementing Inhaled Nitric Oxide for Congenital Diaphragmatic HerniaThe University of Texas Health Science Center, Houston
- RECRUITINGPHASE3NCT07187206Safety and Efficacy of FETO in CDH Phase IIIChildren's Hospital Medical Center, Cincinnati
- RECRUITINGNANCT07166172Prospective Registry for Long-term Outcomes Following FETO in Severe Left and Right CDHJohns Hopkins University
- RECRUITINGNANCT06884423Safety and Efficacy of FETO in CDH: A Phase III TrialHolly L Hedrick, MD
- RECRUITINGNANCT06739356North American Fetal Therapy Network for Long-term Outcome Following Fetoscopic Endoluminal Tracheal Occlusion in Severe Left and Right Congenital Diaphragmatic HerniaThe University of Texas Health Science Center, Houston
- RECRUITINGNANCT03138863Fetal Endoscopic Tracheal Occlusion for Congenital Diaphragmatic Hernia (FETO)Rodrigo Ruano